Insmed Inc. buy Barclays PLC
Start price
11.04.24
/
50%
€26.80
Target price
11.04.25
€37.34
Performance (%)
-12.69%
Price
26.04.24
€23.00
Summary
This prediction is currently active. The prediction for Insmed Inc. disappoints with a performance of -12.69%. This prediction currently runs until 11.04.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Insmed Inc. | 1.770% |
| iShares Core DAX® | 0.961% |
| iShares Nasdaq 100 | 2.626% |
| iShares Nikkei 225® | 0.217% |
| iShares S&P 500 | 1.540% |
Comments by Barclays_PLC for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Barclays PLC from $37.00 to $40.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat